These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21141266)

  • 21. Pattern analysis and variations in the utilization of antihypertensive drugs in Taiwan: a six-year study.
    Huang LY; Shau WY; Chen HC; Su S; Yang MC; Yeh HL; Lai MS
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):410-9. PubMed ID: 23426547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of a health insurance company database for study of theoretical exposure to hypolipidemic agents].
    Vlcek J; Kocová M; Kucera Z; Macek K; Vitásek Z; Ulmanová D
    Vnitr Lek; 2002 Aug; 48(8):742-8. PubMed ID: 12425205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history?
    Kalaba M; Godman B; Vuksanović A; Bennie M; Malmström RE
    J Comp Eff Res; 2012 Nov; 1(6):539-49. PubMed ID: 24236473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
    Furtado C; Pinto M
    Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The evolution of use of anti-Parkinson drugs in Spain].
    Montané E; Vallano Ferraz A; Castel JM
    Rev Neurol; 2002 Apr 1-15; 34(7):612-7. PubMed ID: 12080509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in antihypertensives use among Moroccan patients.
    Berrada El Azizi G; Ahid S; Ghanname I; Belaiche A; Hassar M; Cherrah Y
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1067-73. PubMed ID: 22585420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dispensation and cost of antimicrobials in Spain (1998-2000)].
    Abasolo Osinaga E; Abecia Inchaurregui LC; Bañares Onraita MT; Rada Fernández de Jáuregui D
    Rev Esp Quimioter; 2005 Dec; 18(4):300-7. PubMed ID: 16446789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D.
    Frankenfield DL; Weinhandl ED; Powers CA; Howell BL; Herzog CA; St Peter WL
    Am J Kidney Dis; 2012 May; 59(5):670-81. PubMed ID: 22206743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiac insufficiency: therapeutic aspects in the elderly person].
    Perrenoud JJ
    Praxis (Bern 1994); 1996 Feb; 85(6):164-7. PubMed ID: 8701179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Consumption and cost of antipsychotic drugs].
    Pérez J; Marín N; Vallano A; Castells X; Capellà D
    Actas Esp Psiquiatr; 2005; 33(2):110-6. PubMed ID: 15768318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular drugs in Czechoslovakia--registration and consumption data.
    Seflová M; Sechser T; Strnadová J; Skop B; Váchová M; Svihovec J
    Pol J Pharmacol Pharm; 1989; 41(6):533-7. PubMed ID: 2485903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003-2012.
    Lisauskienė I; Garuolienė K; Gulbinovič J
    Medicina (Kaunas); 2017; 53(4):259-267. PubMed ID: 28844562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic left heart ventricle failure and inotropic stimulation].
    Myhre ES; Gundersen T; Dickstein K; Hole T; Kjekshus J; Rønnevik P; Smith P; Westheim A
    Tidsskr Nor Laegeforen; 1995 Jan; 115(3):360-4. PubMed ID: 7855836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-lowering drugs: use and expenditure in Portugal (1995-2004).
    Teixeira IJ; Escoval A; Schiappa M
    Rev Port Cardiol; 2007 May; 26(5):475-93. PubMed ID: 17691275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.
    Cooke C; Nissen L; Sketris I; Tett SE
    Clin Ther; 2005 Apr; 27(4):497-508. PubMed ID: 15922822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.
    Jochmann N; Stangl K; Garbe E; Baumann G; Stangl V
    Eur Heart J; 2005 Aug; 26(16):1585-95. PubMed ID: 15996977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk, drugs and erectile function--a systematic analysis.
    Baumhäkel M; Schlimmer N; Kratz M; Hackett G; Jackson G; Böhm M
    Int J Clin Pract; 2011 Mar; 65(3):289-98. PubMed ID: 21314866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.